Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2000
01/27/2000CA2332025A1 Measuring nitric oxide concentration in tissue
01/27/2000CA2270797A1 Transparent flow through membrane for dry reagent analytical devices
01/27/2000CA2269162A1 Method for the determination of analyte concentration in a lateral flow sandwich immunoassay exhibiting high-dose hook effect
01/26/2000EP0974842A1 Reagent for examining agglutination of virus and kit for virus examination
01/26/2000EP0974841A2 Suppression of interference in immunoassays using substances derived from the framework regions of antibodies
01/26/2000EP0974840A2 Fluidic device for medical diagnostics
01/26/2000EP0974839A1 Method for quickly determining the resistivity index of solid samples, such as rock samples
01/26/2000EP0974671A1 Method for diagnosing bone dysbolism
01/26/2000EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme
01/26/2000EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy
01/26/2000EP0974655A2 G-CSF analog compositions and methods
01/26/2000EP0974652A1 Cancerous metastasis-associated gene
01/26/2000EP0974648A1 Novel cell line and screening method with the use of the same
01/26/2000EP0974303A1 Method and instrument for measuring blood sugar level
01/26/2000EP0974225A1 Method and device for determining the color appearance of color overprints
01/26/2000EP0974061A1 Test element storage device
01/26/2000EP0974060A1 Determination of % glycated hemoglobin
01/26/2000EP0974059A1 Preparation of blood samples for detecting homocysteine and/or folate
01/26/2000EP0974058A2 20 human secreted proteins
01/26/2000EP0974057A1 Methods to detect hk2 polypeptides
01/26/2000EP0974056A1 Prenatal diagnostic methods
01/26/2000EP0974055A1 Titration method for a complex viral composition
01/26/2000EP0974053A1 Detection of low level hydrophobic analytes in environmental samples
01/26/2000EP0974052A1 Substances to correct aberrant gene product fonction
01/26/2000EP0974051A1 A method to identify plant proteins that function in g-protein coupled systems and compositions therefor
01/26/2000EP0974050A1 Basophil degranulation test
01/26/2000EP0974047A1 Flow detection apparatus and method
01/26/2000EP0974044A1 Laser capture microdissection analysis vessel
01/26/2000EP0973997A1 Method and apparatus for the downhole compositional analysis of formation gases
01/26/2000EP0973946A1 Biological assay for testing the carcinogenic properties of a substance
01/26/2000EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
01/26/2000EP0973942A2 Screening method for proline-rich proteins
01/26/2000EP0973937A1 Method of selectively determining a fungal biomass
01/26/2000EP0973936A1 Combinatorial libraries of peptidomimetic aminothioether acids
01/26/2000EP0973935A2 Target genes for allele-specific drugs
01/26/2000EP0973933A1 Immunological tolerance to hiv epitopes
01/26/2000EP0973923A1 IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING
01/26/2000EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
01/26/2000EP0973893A1 Intracellular amyloid-beta binding (erab) polypeptide
01/26/2000EP0973889A1 Human calcium channels alfa1 subunits and related probes, cell lines and methods
01/26/2000EP0973876A1 DNA ENCODING $i(PNEUMOCYSTIS CARINII) PROTEASE
01/26/2000EP0973863A1 Method and devices for partitioning biological sample liquids into microvolumes
01/26/2000EP0973805A1 Method for production of antibodies to specific sites of rapamycin
01/26/2000EP0973802A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
01/26/2000EP0973801A1 GnRH ANTAGONISTS
01/26/2000EP0973794A1 Netrin receptors
01/26/2000EP0973785A1 Trans-platinum compound, and diagnostic kit
01/26/2000EP0973541A1 Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterising cancer cells with individual properties
01/26/2000EP0973537A1 Cocaethylene immunogens and antibodies
01/26/2000EP0973456A1 Method of discriminating bacterial from aseptic meningitis
01/26/2000EP0973381A2 Animal model for evaluation of vaccines
01/26/2000EP0973380A1 Model for chronic cerebral inflammation by intracerebral injection of polynucleotide
01/26/2000EP0800649A4 Inhibition of glial cell proliferation
01/26/2000EP0743870B1 Preparation and application of artificial anti-idiotypic imprints
01/26/2000EP0700305B1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
01/26/2000CN1242835A Characterization of liquid misting
01/26/2000CN1242834A Testing device and method of use
01/26/2000CN1242802A Notch protein and their ligands
01/26/2000CN1242521A Method for investigating polypeptide (Protein) genital hormone content in human body by analysing hair therewith
01/26/2000CN1242430A Macro-fragment deoxyribonucleic acid core piece and method for mfg. same
01/26/2000CN1242429A Papain blood group diagnose reagent prepn. method
01/26/2000CN1048808C Agent box for testing high blood lipid, and method for preparing same
01/26/2000CN1048807C Apparatus and method for measuring trash in fiber samples
01/26/2000CN1048756C Measurement of mold growth on amorphous substrates
01/26/2000CN1048731C Polynucleotide of drug binding protein as coded CSAID
01/25/2000USRE36536 Method of detecting a substance using enzymatically-induced decomposition of dioxetanes
01/25/2000US6018587 Method for remote sensing analysis be decorrelation statistical analysis and hardware therefor
01/25/2000US6018105 Nucleotide sequences; for expressing modified forms of herbicide target enzymes for herbicide resistant plants
01/25/2000US6018097 Transgenic mice expressing human insulin
01/25/2000US6018047 Acridinium compounds as chemiluminogenic label
01/25/2000US6018027 A polypeptide encoding a nucleic acid having morphology of herpes virus and a double stranded dna genome designated as a new human b lymphotropic virus; diagnosis and therapy
01/25/2000US6018025 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target
01/25/2000US6018024 A soluble fragment of amyloid protein having the carboxy terminal methionine or leucine amino acid resulting from cleavage of the intact protein; diagnosis and therapy for alzheimer's disease
01/25/2000US6018023 Kainate-binding, human CNS receptors of the EAA3 family
01/25/2000US6018022 Modification of pertussis toxin
01/25/2000US6018019 Immunogenic synthetic peptides which are useful alone or in conjugates in vaccines against hemophilus influenza infection
01/25/2000US6017769 Non-enzymatic methods of generating chemiluminescence from acridan alkenes
01/25/2000US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma
01/25/2000US6017767 A chromatographic device with opposable components for sample preparation and chromographic medium, so that when the two components are brought into opposition the sample is applied to the medium; diagnosis/monitoring biological samples
01/25/2000US6017757 A homogenous cell population of parasitic cells obtained by in-vitro culturing of differentiated intestinal cells of a nematode; therapy and prevention of parasitic infections in animals
01/25/2000US6017742 Immobilization of biologically active substances on a carrier containing a carbodiimide group-containing polymer
01/25/2000US6017732 To screen for enhanced specfic binding pair binding
01/25/2000US6017729 Receptor activator of NF-κB
01/25/2000US6017721 Chromatographic method and device for preparing blood serum for compatibility testing
01/25/2000US6017719 Targeting cells from heterogeneous suspension; forming cell complexes linked to antibody bound to surface antigen, separating complexes, mixing antibody with peptide that binds and displaces antibody from antigen, releasing target cell
01/25/2000US6017718 Measuring the concentration of protein in a urine sample and comparing the concentration to a baseline concentration; increased concentrations indicate the presence of disease
01/25/2000US6017716 Mixing biological sample with an isolated protein and determining binding of antibodies in sample to protein; antibody binding idicates melanoma
01/25/2000US6017715 Quick and sensitive immunoassay by adding antibody specific to toxicant to the sample, incubating to form complex, comparing toxicity of antibody treated sample to untreated sample; reduction in toxicity indicates contribution
01/25/2000US6017714 Netrins
01/25/2000US6017713 Ferritin formation as an predictor of iron availability in foods
01/25/2000US6017711 Bacterial diagnostic probe
01/25/2000US6017706 Process for identifying compounds which protect against the formation of fluorescent light induced DNA lesions and x-ray-induced lesions
01/25/2000US6017703 Screening for bladder cancer by detecting the presences of a tumor-associated human complement factor h antigen in a biological sample by hybridization and amplification by polymerase chain reaction
01/25/2000US6017698 Providing a sample liquid containing a biological material in a sample vessel having a hollow structure form containing a porous matrix capable of binding a biological material by allowing the sample liquid to pass through the matrix
01/25/2000US6017696 Controlling nucleic acid hybridization by connecting multiple electrical sources to several location where a plurality of nucleic acids with target nucleic acids are attached, apply a negative potential, removing non specific nucleic acid
01/25/2000US6017695 A polynucleotide sequence that encodes a human brain glycoprotein, contactin; to study signal transmissions, cell morphology, cell metabolism and cell adhesion
01/25/2000US6017693 Analyzing oligonucleotide fragments, comparing to calculated mass spectra of nucleotide sub-sequences stored in database, calculating closeness-of-fit measure to determine best matches
01/25/2000US6017541 Methyl ecgonine phenylphosphonates as analogues of transition states for the hydrolysis of the benzoyl ester of an ecgonine derivative, namely cocaine, and their linking to carrier proteins for use as immunogens
01/25/2000US6017539 Multimeric hybrid genes encoding corresponding chimeric protein comprise gene sequence coding for antigenic region of protein from first pathogen linked to gene sequence coding for antigenic region of protein from second pathogen
01/25/2000US6017533 Assessing the signal transduction ability of pacap type 1 receptor-expressing cells in a mammalian tissue by contacting them with an agonist/antagonist peptide and assaying the affinity